England
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.69 (0.60 - 0.78) | 2019 | Modelled | IHME |
| 0.69 (0.60 - 0.78) | 2018 | Modelled | IHME |
| 0.69 (0.60 - 0.78) | 2017 | Modelled | IHME |
| 0.69 (0.61 - 0.78) | 2016 | Modelled | IHME |
| 0.69 (0.61 - 0.78) | 2015 | Modelled | IHME |
| 0.7 (0.61 - 0.78) | 2014 | Modelled | IHME |
| 0.7 (0.61 - 0.78) | 2013 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2012 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2011 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2010 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2009 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2008 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2007 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2006 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2005 | Modelled | IHME |
| 0.7 (0.61 - 0.79) | 2004 | Modelled | IHME |
| 0.69 (0.60 - 0.78) | 2003 | Modelled | IHME |
| 0.68 (0.59 - 0.78) | 2002 | Modelled | IHME |
| 0.68 (0.59 - 0.77) | 2001 | Modelled | IHME |
| 0.67 (0.59 - 0.76) | 2000 | Modelled | IHME |
| 0.67 (0.59 - 0.76) | 1999 | Modelled | IHME |
| 0.67 (0.58 - 0.77) | 1998 | Modelled | IHME |
| 0.68 (0.58 - 0.77) | 1997 | Modelled | IHME |
| 0.68 (0.58 - 0.77) | 1996 | Modelled | IHME |
| 0.68 (0.58 - 0.77) | 1995 | Modelled | IHME |
| 0.68 (0.58 - 0.77) | 1994 | Modelled | IHME |
| 0.68 (0.58 - 0.77) | 1993 | Modelled | IHME |
| 0.67 (0.58 - 0.77) | 1992 | Modelled | IHME |
| 0.67 (0.58 - 0.77) | 1991 | Modelled | IHME |
| 0.67 (0.58 - 0.77) | 1990 | Modelled | IHME |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.07 (0.05 - 0.09) | 2019 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2018 | Modelled | IHME |
| 0.08 (0.06 - 0.10) | 2017 | Modelled | IHME |
| 0.2 (0.15 - 0.25) | 2016 | Modelled | IHME |
| 0.31 (0.23 - 0.40) | 2015 | Modelled | IHME |
| 0.32 (0.24 - 0.40) | 2014 | Modelled | IHME |
| 0.32 (0.24 - 0.40) | 2013 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2012 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2011 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2010 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2009 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2008 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2007 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2006 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2005 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2004 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2003 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2002 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2001 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 2000 | Modelled | IHME |
| 0.32 (0.24 - 0.41) | 1999 | Modelled | IHME |
| 0.33 (0.24 - 0.41) | 1998 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1997 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1996 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1995 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1994 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1993 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1992 | Modelled | IHME |
| 0.33 (0.25 - 0.42) | 1991 | Modelled | IHME |
| 0.34 (0.25 - 0.42) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 1.89 (1.66 - 2.11) | 2019 | Modelled | IHME |
| 1.9 (1.67 - 2.13) | 2018 | Modelled | IHME |
| 1.92 (1.69 - 2.14) | 2017 | Modelled | IHME |
| 1.91 (1.68 - 2.12) | 2016 | Modelled | IHME |
| 1.88 (1.66 - 2.09) | 2015 | Modelled | IHME |
| 1.83 (1.62 - 2.04) | 2014 | Modelled | IHME |
| 1.81 (1.60 - 2.02) | 2013 | Modelled | IHME |
| 1.77 (1.57 - 1.98) | 2012 | Modelled | IHME |
| 1.75 (1.55 - 1.95) | 2011 | Modelled | IHME |
| 1.73 (1.53 - 1.93) | 2010 | Modelled | IHME |
| 1.7 (1.51 - 1.90) | 2009 | Modelled | IHME |
| 1.69 (1.49 - 1.88) | 2008 | Modelled | IHME |
| 1.64 (1.46 - 1.83) | 2007 | Modelled | IHME |
| 1.6 (1.42 - 1.78) | 2006 | Modelled | IHME |
| 1.55 (1.38 - 1.72) | 2005 | Modelled | IHME |
| 1.51 (1.34 - 1.68) | 2004 | Modelled | IHME |
| 1.48 (1.31 - 1.65) | 2003 | Modelled | IHME |
| 1.42 (1.26 - 1.58) | 2002 | Modelled | IHME |
| 1.36 (1.20 - 1.51) | 2001 | Modelled | IHME |
| 1.31 (1.16 - 1.47) | 2000 | Modelled | IHME |
| 1.27 (1.13 - 1.42) | 1999 | Modelled | IHME |
| 1.22 (1.08 - 1.36) | 1998 | Modelled | IHME |
| 1.16 (1.03 - 1.29) | 1997 | Modelled | IHME |
| 1.1 (0.98 - 1.23) | 1996 | Modelled | IHME |
| 1.06 (0.94 - 1.18) | 1995 | Modelled | IHME |
| 1.01 (0.89 - 1.13) | 1994 | Modelled | IHME |
| 0.98 (0.87 - 1.10) | 1993 | Modelled | IHME |
| 0.96 (0.85 - 1.07) | 1992 | Modelled | IHME |
| 0.94 (0.83 - 1.05) | 1991 | Modelled | IHME |
| 0.91 (0.81 - 1.03) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,069 (937 - 1,196) | 2019 | Modelled | IHME |
| 1,068 (939 - 1,197) | 2018 | Modelled | IHME |
| 1,073 (945 - 1,198) | 2017 | Modelled | IHME |
| 1,060 (935 - 1,181) | 2016 | Modelled | IHME |
| 1,037 (916 - 1,155) | 2015 | Modelled | IHME |
| 1,007 (891 - 1,122) | 2014 | Modelled | IHME |
| 987 (875 - 1,101) | 2013 | Modelled | IHME |
| 960 (849 - 1,072) | 2012 | Modelled | IHME |
| 940 (835 - 1,048) | 2011 | Modelled | IHME |
| 923 (818 - 1,031) | 2010 | Modelled | IHME |
| 901 (799 - 1,003) | 2009 | Modelled | IHME |
| 884 (784 - 987) | 2008 | Modelled | IHME |
| 854 (757 - 953) | 2007 | Modelled | IHME |
| 827 (735 - 921) | 2006 | Modelled | IHME |
| 795 (707 - 882) | 2005 | Modelled | IHME |
| 768 (683 - 854) | 2004 | Modelled | IHME |
| 749 (665 - 833) | 2003 | Modelled | IHME |
| 714 (632 - 795) | 2002 | Modelled | IHME |
| 680 (601 - 757) | 2001 | Modelled | IHME |
| 653 (578 - 729) | 2000 | Modelled | IHME |
| 630 (558 - 704) | 1999 | Modelled | IHME |
| 599 (530 - 669) | 1998 | Modelled | IHME |
| 568 (503 - 633) | 1997 | Modelled | IHME |
| 539 (478 - 601) | 1996 | Modelled | IHME |
| 516 (457 - 574) | 1995 | Modelled | IHME |
| 489 (432 - 545) | 1994 | Modelled | IHME |
| 474 (420 - 529) | 1993 | Modelled | IHME |
| 461 (407 - 516) | 1992 | Modelled | IHME |
| 449 (396 - 505) | 1991 | Modelled | IHME |
| 438 (387 - 492) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 12 (10 - 14) | 2019 | Modelled | IHME |
| 12 (10 - 14) | 2018 | Modelled | IHME |
| 12 (10 - 14) | 2017 | Modelled | IHME |
| 12 (10 - 14) | 2016 | Modelled | IHME |
| 12 (10 - 14) | 2015 | Modelled | IHME |
| 12 (10 - 14) | 2014 | Modelled | IHME |
| 12 (10 - 14) | 2013 | Modelled | IHME |
| 12 (10 - 14) | 2012 | Modelled | IHME |
| 12 (10 - 14) | 2011 | Modelled | IHME |
| 12 (10 - 14) | 2010 | Modelled | IHME |
| 12 (10 - 14) | 2009 | Modelled | IHME |
| 12 (10 - 14) | 2008 | Modelled | IHME |
| 12 (10 - 14) | 2007 | Modelled | IHME |
| 12 (10 - 14) | 2006 | Modelled | IHME |
| 12 (10 - 14) | 2005 | Modelled | IHME |
| 12 (10 - 14) | 2004 | Modelled | IHME |
| 12 (10 - 14) | 2003 | Modelled | IHME |
| 12 (10 - 14) | 2002 | Modelled | IHME |
| 12 (10 - 14) | 2001 | Modelled | IHME |
| 12 (10 - 15) | 2000 | Modelled | IHME |
| 12 (10 - 15) | 1999 | Modelled | IHME |
| 12 (10 - 15) | 1998 | Modelled | IHME |
| 12 (10 - 15) | 1997 | Modelled | IHME |
| 12 (10 - 15) | 1996 | Modelled | IHME |
| 13 (10 - 15) | 1995 | Modelled | IHME |
| 13 (10 - 15) | 1994 | Modelled | IHME |
| 13 (10 - 15) | 1993 | Modelled | IHME |
| 13 (10 - 15) | 1992 | Modelled | IHME |
| 13 (11 - 15) | 1991 | Modelled | IHME |
| 13 (11 - 15) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
None
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Yes
Eligible for HCV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.1 (0.89 - 1.34) | 2019 | Modelled | IHME |
| 1.1 (0.89 - 1.34) | 2018 | Modelled | IHME |
| 1.1 (0.89 - 1.34) | 2017 | Modelled | IHME |
| 1.33 (1.08 - 1.63) | 2016 | Modelled | IHME |
| 1.61 (1.31 - 1.98) | 2015 | Modelled | IHME |
| 1.71 (1.39 - 2.10) | 2014 | Modelled | IHME |
| 1.8 (1.47 - 2.21) | 2013 | Modelled | IHME |
| 1.86 (1.52 - 2.29) | 2012 | Modelled | IHME |
| 1.91 (1.55 - 2.34) | 2011 | Modelled | IHME |
| 1.92 (1.56 - 2.36) | 2010 | Modelled | IHME |
| 1.92 (1.56 - 2.36) | 2009 | Modelled | IHME |
| 1.91 (1.56 - 2.35) | 2008 | Modelled | IHME |
| 1.91 (1.55 - 2.35) | 2007 | Modelled | IHME |
| 1.89 (1.54 - 2.33) | 2006 | Modelled | IHME |
| 1.88 (1.53 - 2.32) | 2005 | Modelled | IHME |
| 1.78 (1.45 - 2.19) | 2004 | Modelled | IHME |
| 1.56 (1.27 - 1.92) | 2003 | Modelled | IHME |
| 1.3 (1.06 - 1.60) | 2002 | Modelled | IHME |
| 1.08 (0.88 - 1.33) | 2001 | Modelled | IHME |
| 0.98 (0.79 - 1.20) | 2000 | Modelled | IHME |
| 0.97 (0.78 - 1.18) | 1999 | Modelled | IHME |
| 0.96 (0.77 - 1.17) | 1998 | Modelled | IHME |
| 0.95 (0.77 - 1.16) | 1997 | Modelled | IHME |
| 0.94 (0.76 - 1.15) | 1996 | Modelled | IHME |
| 0.94 (0.76 - 1.15) | 1995 | Modelled | IHME |
| 0.94 (0.76 - 1.15) | 1994 | Modelled | IHME |
| 0.94 (0.76 - 1.15) | 1993 | Modelled | IHME |
| 0.94 (0.76 - 1.15) | 1992 | Modelled | IHME |
| 0.93 (0.76 - 1.15) | 1991 | Modelled | IHME |
| 0.93 (0.76 - 1.15) | 1990 | Modelled | IHME |
Showing out of
Show more
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 28 | 2018 | Survey/reported | Public Health England, 2020 |
Prevalence of anti-HCV
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 30.7 (26.90 - 34.60) | 2013 | Modelled | Degenhardt L et al, 2017 |
| 55 | 2018 | Survey/reported | Public Health England, 2020 |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.82 (3.37 - 4.21) | 2019 | Modelled | IHME |
| 3.85 (3.41 - 4.25) | 2018 | Modelled | IHME |
| 3.91 (3.47 - 4.31) | 2017 | Modelled | IHME |
| 3.88 (3.46 - 4.27) | 2016 | Modelled | IHME |
| 3.82 (3.41 - 4.20) | 2015 | Modelled | IHME |
| 3.72 (3.32 - 4.08) | 2014 | Modelled | IHME |
| 3.62 (3.24 - 3.98) | 2013 | Modelled | IHME |
| 3.51 (3.13 - 3.86) | 2012 | Modelled | IHME |
| 3.38 (3.02 - 3.72) | 2011 | Modelled | IHME |
| 3.26 (2.93 - 3.57) | 2010 | Modelled | IHME |
| 3.14 (2.81 - 3.44) | 2009 | Modelled | IHME |
| 3.04 (2.75 - 3.34) | 2008 | Modelled | IHME |
| 2.92 (2.65 - 3.20) | 2007 | Modelled | IHME |
| 2.8 (2.54 - 3.07) | 2006 | Modelled | IHME |
| 2.68 (2.43 - 2.93) | 2005 | Modelled | IHME |
| 2.58 (2.34 - 2.82) | 2004 | Modelled | IHME |
| 2.5 (2.27 - 2.75) | 2003 | Modelled | IHME |
| 2.4 (2.18 - 2.62) | 2002 | Modelled | IHME |
| 2.29 (2.07 - 2.50) | 2001 | Modelled | IHME |
| 2.21 (2.01 - 2.41) | 2000 | Modelled | IHME |
| 2.15 (1.95 - 2.35) | 1999 | Modelled | IHME |
| 2.05 (1.87 - 2.24) | 1998 | Modelled | IHME |
| 1.97 (1.79 - 2.15) | 1997 | Modelled | IHME |
| 1.88 (1.71 - 2.06) | 1996 | Modelled | IHME |
| 1.82 (1.65 - 1.99) | 1995 | Modelled | IHME |
| 1.75 (1.59 - 1.91) | 1994 | Modelled | IHME |
| 1.71 (1.55 - 1.87) | 1993 | Modelled | IHME |
| 1.7 (1.54 - 1.86) | 1992 | Modelled | IHME |
| 1.67 (1.51 - 1.82) | 1991 | Modelled | IHME |
| 1.63 (1.48 - 1.78) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,158 (1,909 - 2,385) | 2019 | Modelled | IHME |
| 2,165 (1,919 - 2,394) | 2018 | Modelled | IHME |
| 2,186 (1,941 - 2,412) | 2017 | Modelled | IHME |
| 2,159 (1,921 - 2,372) | 2016 | Modelled | IHME |
| 2,110 (1,883 - 2,319) | 2015 | Modelled | IHME |
| 2,041 (1,825 - 2,242) | 2014 | Modelled | IHME |
| 1,976 (1,765 - 2,171) | 2013 | Modelled | IHME |
| 1,900 (1,696 - 2,088) | 2012 | Modelled | IHME |
| 1,817 (1,623 - 1,997) | 2011 | Modelled | IHME |
| 1,735 (1,561 - 1,904) | 2010 | Modelled | IHME |
| 1,658 (1,485 - 1,817) | 2009 | Modelled | IHME |
| 1,595 (1,441 - 1,750) | 2008 | Modelled | IHME |
| 1,521 (1,376 - 1,667) | 2007 | Modelled | IHME |
| 1,445 (1,310 - 1,582) | 2006 | Modelled | IHME |
| 1,374 (1,244 - 1,502) | 2005 | Modelled | IHME |
| 1,313 (1,192 - 1,436) | 2004 | Modelled | IHME |
| 1,264 (1,145 - 1,388) | 2003 | Modelled | IHME |
| 1,206 (1,096 - 1,318) | 2002 | Modelled | IHME |
| 1,145 (1,036 - 1,249) | 2001 | Modelled | IHME |
| 1,100 (999 - 1,200) | 2000 | Modelled | IHME |
| 1,062 (968 - 1,161) | 1999 | Modelled | IHME |
| 1,013 (920 - 1,106) | 1998 | Modelled | IHME |
| 965 (876 - 1,055) | 1997 | Modelled | IHME |
| 919 (834 - 1,004) | 1996 | Modelled | IHME |
| 884 (802 - 966) | 1995 | Modelled | IHME |
| 850 (769 - 928) | 1994 | Modelled | IHME |
| 827 (751 - 902) | 1993 | Modelled | IHME |
| 819 (741 - 895) | 1992 | Modelled | IHME |
| 801 (726 - 875) | 1991 | Modelled | IHME |
| 781 (709 - 852) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 41 (37 - 45) | 2019 | Modelled | IHME |
| 41 (38 - 45) | 2018 | Modelled | IHME |
| 41 (38 - 45) | 2017 | Modelled | IHME |
| 41 (37 - 45) | 2016 | Modelled | IHME |
| 41 (37 - 45) | 2015 | Modelled | IHME |
| 41 (37 - 45) | 2014 | Modelled | IHME |
| 41 (37 - 45) | 2013 | Modelled | IHME |
| 41 (37 - 45) | 2012 | Modelled | IHME |
| 41 (37 - 45) | 2011 | Modelled | IHME |
| 40 (37 - 44) | 2010 | Modelled | IHME |
| 40 (36 - 44) | 2009 | Modelled | IHME |
| 40 (36 - 44) | 2008 | Modelled | IHME |
| 40 (36 - 44) | 2007 | Modelled | IHME |
| 40 (36 - 44) | 2006 | Modelled | IHME |
| 39 (36 - 44) | 2005 | Modelled | IHME |
| 39 (36 - 43) | 2004 | Modelled | IHME |
| 39 (36 - 43) | 2003 | Modelled | IHME |
| 39 (36 - 43) | 2002 | Modelled | IHME |
| 40 (36 - 43) | 2001 | Modelled | IHME |
| 39 (36 - 43) | 2000 | Modelled | IHME |
| 40 (36 - 44) | 1999 | Modelled | IHME |
| 40 (36 - 44) | 1998 | Modelled | IHME |
| 40 (36 - 44) | 1997 | Modelled | IHME |
| 40 (36 - 44) | 1996 | Modelled | IHME |
| 40 (36 - 44) | 1995 | Modelled | IHME |
| 40 (36 - 44) | 1994 | Modelled | IHME |
| 40 (36 - 44) | 1993 | Modelled | IHME |
| 40 (36 - 44) | 1992 | Modelled | IHME |
| 40 (36 - 44) | 1991 | Modelled | IHME |
| 40 (36 - 44) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
None
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Yes
Eligible for HCV generic medicines
Overview
HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030
Prevalence (national)
Modelled
HBV (HBsAg+)
0.69
(%)
2019
(0.6 - 0.78(%))
IHME
HCV (RNA/cAg+)
1.1
(%)
2019
(0.89 - 1.34(%))
IHME
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,069
2019
(937 - 1,196)
IHME
Survey/surveillance
No data available
HBV chart
Modelled
HCV
2,158
2019
(1,909 - 2,385)
IHME
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
0.07
(%)
2019, latest modelled
(0.05 - 0.09(%))
IHME
Prevalence PWID
HCV
55
(%)
2018, survey/surveillance
Public Health England, 2020
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines